{{Rsnum
|rsid=8070723
|Gene=MAPT
|Chromosome=17
|position=46003698
|Orientation=plus
|GMAF=0.1455
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=MAPT
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 59.3 | 39.8 | 0.9
| HCB | 100.0 | 0.0 | 0.0
| JPT | 99.1 | 0.9 | 0.0
| YRI | 75.5 | 23.8 | 0.7
| ASW | 56.1 | 42.1 | 1.8
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 82.2 | 16.8 | 1.0
| LWK | 77.1 | 22.0 | 0.9
| MEX | 73.7 | 17.5 | 8.8
| MKK | 75.5 | 20.6 | 3.9
| TSI | 42.2 | 44.1 | 13.7
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21044948
|Trait=None
|Title=Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21
|RiskAllele=
|Pval=7E-12
|OR=1.3000
|ORtxt=[1.19-1.43]
|OA=1
}}
Each copy of the G version of [[rs8070723]] was associated with about 5.5 times lower odds of [[progressive supranuclear palsy]]. The researchers identified smaller effects  at [[rs1411478]], [[rs7571971]] and [[rs1768208]]. [http://blog.23andme.com/2011/07/15/snpwatch-genetic-variants-linked-to-progressive-supranuclear-palsy/ 23andMe blog]

{{PMID Auto GWAS
|PMID=21685912
|Trait=None
|Title=Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.
|RiskAllele=
|Pval=2E-118
|OR=5.1100
|ORtxt=[4.43-5.91]
|OA=1
}}

{{PMID|18985386|OA=1
}} Genomewide association study for susceptibility genes contributing to familial Parkinson disease.

{{PMID|20070850|OA=1
}} Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}